Aditya Bardia, MD, MPH, Attending Physician, Massachusetts General Hospital, Harvard Medical School, gives an overview of the Snapshot assay for breast cancer.
Aditya Bardia, MD, MPH, attending physician, Massachusetts General Hospital, Harvard Medical School, gives an overview of the Snapshot assay for breast cancer.
Snapshot looks at the 130 most common mutations by using multiplex PCR to amplify mutations in breast cancer. In the 4-year review presented at the 2013 Breast Cancer Symposium, the assay was ordered by physicians for patients with metastatic breast cancer.
Bardia says that more genotyping assays are being offered by various institutions, and that is important for community oncologists to understand cancer mutations. Snapshot is a particularly good assay because it only looks at actionable mutations.
Sequencing Sacituzumab and Other Drugs in HR+, HER2- Breast Cancer
May 16th 2024During a Case-Based Roundtable® event, Stephanie L. Graff, MD, discussed multiple later-line treatment options in hormone receptor–positive breast cancer with participants in the first article of a 2-part series.
Read More
Darolutamide Becomes Routine Doublet and Triplet Option in Hormone-Sensitive Prostate Cancer
May 6th 2024Darolutamide has been adopted routinely in clinical practice as a component of both doublet and triplet regimens for the treatment of patients with metastatic hormone-sensitive prostate cancer.
Read More